ArmstrongPKeevilSF. Magnetic resonance imaging-2: Clinical issues. Br Med J, 1991; 303: 105–109.
2.
PhilipponJCornuP. The recurrence of meningiomas. In: Meningiomas1991 101–103. Ed Al-MeftyO. Raven Press Ltd, New York.
3.
ZimmermanRD. Magnetic resonance imaging of intracranial meningiomas. In: Meningiomas1991209–223. Ed: Al-MeftyO. Raven Press Ltd.New York.
4.
HodgsonTJKingsleyDPEMoseleyIF. The role of imaging in the follow-up of meningiomas. Journal of Neurology, Neurosurgery and Psychiatry, 1995; 59: 545–47.
5.
MurtaghRLindenC. Neuroimaging of intracranial meningiomas. Neurosurgery Clinics of North America, 1994; 5: 217–33.
6.
PadfieldPL. Demise of the mercury manometerScot Med J1998; 43, 87–88.
7.
IdeCW. Mercury hazards in sphygmomanometer repairBr Med J1986;293;1409–10.
8.
GillespieNdmetMcMurdoMET. Falls in old age: Inevitable or preventable?Scot Med J1998; 43(4): 101–103.
9.
LipGYHTeanKNDunnFG. Treatment of atrial fibrillation in a district general hospital. Br Heart J, 1994; 71: 92–95.
10.
RebelloRBrownleeWC. Intermittent ventricular standstill during chronic atrial fibrillation in patients with dizziness or syncope. PACE, 1987; 10: 1271–76.
11.
Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med1994; 154: 1449–1457.
12.
The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators. Arch Intern Med1997; 157: 12371240.
13.
Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus lowintensity, fixed-dose warfarin plus aspirin for high risk patients with atrial fibrillation; Stroke Prevention In Atrial Fibrillation III randomized clinical trial. Lancet1996; 348: 633–638.